U.S. Markets closed

Midatech Pharma plc (MTP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.0000-0.0800 (-3.85%)
At close: 4:00PM EDT
2.1000 +0.10 (5.00%)
After hours: 07:41PM EDT
Sign in to post a message.
  • D
    It’s going to pop 🍾🚀
  • M
    I don't know how anyone can make a decision to buy, hold or sell, with so many undisclosed partnerships
  • M
    Upside volume continues. I got in at 1.35. I’m thinking some type of goods news now that the quarter has ended.
  • M
    Anybody notice the buy side trade of 22,000 shares that occurred around 11am today?
  • a
    What is wrong with this stock? I’m trying to poke it with a stick but it doesn’t go up.
  • M
    Upside volume has got me interested. Going to buy the next time this dips into the one forty range.
  • A
    Glad we had the placing and MTP fully funded to 2022.

    The placing was significantly oversubscribed and brings new UK institutions into the Company's shareholder base.

    The fund will be used to:

    1) advance the Company's internal pipeline of Q-Sphera products through proof-of-concept and in vivo studies for potential out-licensing;

    2) develop Q-Sphera technology for unique application with biologic active pharmaceutical ingredients; and

    3) The Broker Option Shares are not being made available to the public

    4) The strategic review initially announced by the Company on 31 March 2020 and updated on 20 April 2020 remains ongoing. i.e. business still open to offers/ sale, as they see fit - although closed formal bid process now closed. Very good.

    ''Out-Licensing'' = means both global phama will need to sign something very soon and pay licence fee for any use with their main products, becuase they are to keep other intellectual rights, This fee would be in addition major milestone payments for the develeopment and testing on Global Phama products (the work) by MTPH.

    5) The shares old to new company investors. Therefore we can expect the new investors the ones who bought to 90p on Tuesday, and this placiing is ther everage down piece. So if new investors in at 60p/ $3 now, 2/3 times that 120-180p / $6-$10 next move possible.

    Buy and hold, stay with the new investors. Let some else sell here (short and mms).
  • A
    The news on Tuesday is major turnaround story just beginning for MTPH. And have a major correction from $6.5, its just getting ready for major retest of new highs. Any news from the company will make it alot easier from here. But techincally its oversold. If you look at the 3 products mains products of the MTPH they have huge value to global phama and which the MTPH has decided to share instead to continue inhouse to commericalisation and to cut costs. Best thing ever for MTPH and in Bio business (as its costly business)

    If you look at TILS it went to over $9 and then back donw to $2.5 as ADR stock corrected down, and know uk is 160p uk, and USA $10+ dollars. Hit high as $13....well if you had bought at $3....thats 400% upside today.

    make no mistake here. At $7.50 you have 300% gain in your pocket. and shorts lose 300% if they don't cover.
  • A
    Some research for serious investors only.

    This is what MTPH has that is one of its kind in the world.

    Q-Sphera - (A Sustained Release Polymer microsphere to delivery treatment to effective cancer/tunour sites)

    3D Pharmaceutical Printing (for acute applications for cancers, inluding effetcive delivery to brain tumours)

    Adapted for microsphere manufacture with controlled solvent exchange
    Piezoelectric droplet ejection from MicroDropdispenser head with internal diameter 30/70 µm

    Droplet ejection frequency 6 kHz enabling laboratory scale production of 10-250 mg mass of dried, solid microparticles

    Scale-up manufacturing blueprint established (Key for Global Phama!)

    This is huge for major Pharma who spend billions of cancer treatments every year.

    Hence why we are in and will continue to add and hold for the forseable future - under accumulation phase.
  • A
    Omg I was in at 6
  • G
    y33t when news gets out you triple your money next year
  • M
    I'm going to hold
    bought at 3.3
    am I right?
  • M
    Mr. Clean
    Going back up past $4
  • A
    buy/hold. Only 2.54m ADR on sale to raise $5M cash for MTP, same as was done in UK for $5M. UK 30P/ USD $1.95.

    All good. MTP now will have £17.5M cash going forward. And working with 2 global phama's. very strong position to be in. Now explains the sidewaus movement for 2 weeks.
  • N
    $INTC conversation
    Great tiMe to buy loading the boat with call option on #INTC and #IBIO and $ctic and #TNXP and #ABUS and #HTBX both #ENTx AND #mtp ARE WITH GREAT RESULTS GREAT BUY AND THE BEST TO DOUBLE TUESDAY IS #immp GOOD LUCK
  • s
    From the sec filing

    Application has been made for 348,215,478 New Ordinary Shares in aggregate to be admitted to trading on AIM (comprising 120,966,718 Placing Shares, 207,792,206 Subscription shares and 19,456,554 Open Offer Shares) (“Admission”). It is expected that Admission will take place at 8.00 a.m. on 26 February 2019. The New Ordinary Shares will rank pari passu with the existing Ordinary Shares. No application has been made for admission of the Warrants to trading on AIM.
    Following Admission, the Company's issued share capital will consist of 409,399,613 Ordinary Shares. There are no Ordinary Shares held in treasury. Therefore, in accordance with the FCA's Disclosure and Transparency Rule 5.6.1, the Company confirms that as at 26 February 2019, the total number of voting rights in the Company will be 409,399,613. Following Admission, this figure may be used by shareholders as the denominator for the calculations by which they determine whether they are required to notify their interest in, or a change to their interest in, Midatech under the Disclosure Guidance and Transparency Rules.
  • V
    CNN Business news posts The 1 analysts offering 12-month price forecasts for Midatech Pharma PLC have a median target of 1,574.74, with a high estimate of 1,574.74 and a low estimate of 1,574.74. The median estimate represents a +51,871.62% increase from the last price of 3.03.!!!
  • M
    Positive News - Midatech Pharma Shares Surge After Positive Diabetes Treatment Results
    Fri Jul 19 07:21:55 2019 EDT
    ( Alliance News ) - Shares in biopharmaceutical firm Midatech Pharma PLC surged Friday after it received positive results from its first-in-human study of its MTX102 diabetes vaccine candidate.
    Shares in Midatech were 13% higher at 5.69 pence in London on Friday.
    The phase one study of MTX102 was in order to assess the safety of the immuno-tolerising vaccine, with five patients diagnosed with type one diabetes selected.
    During the trial, MTX102 was well tolerated by the patients with only local minor local injection reactions and "no serious adverse events" reported.
    "This EU funded programme is an invaluable project to further develop, understand and evaluate Midatech's gold nanoparticle technology, MidaCore," Midatech Chief Executive Officer Craig Cook said.
    "This is the first human study to assess the safety of MidaCore when injected into patients, and we are pleased that the data generated to date validates the technology as a potentially innovative treatment platform for medical applications", Cook added.
  • N
    $HTBX conversation
    This morning the early bird catches the worm buy #NOVN and #IBIO as well as #htbx and #immp and #MTP should be very good buy at this price #abus will hit A $30 ove wining #mrna patent, #ABUS will help COVD stocks to push higher #NOVN is and have the patent to many Covd stocks this will do realy well.. #HTBX approach is amazing as well as plant based vaccine=#IBIO
  • S
    MTP preferred shares are up over 300% to $86.50 check it out. MTP will be a rocket tomorrow.